Best Alcohol and Drug Rehab NJ in Brooklawn, NJ

Jeffrey A. Berman, MD, FASAM is a Diplomate and Fellow of the American Society of Addiction Medicine. He is the Executive Medical Director of Discovery Institute for Addictive Disorders in Marlboro, NJ and Clinical Assistant Professor of Psychiatry at the Robert Wood Johnson Medical School. He was recruited from Bergen Regional Medical Center, NJ’s largest acute psychiatric hospital, where he served as Director of Chemical Dependency Services to join Discovery Institute in Marlboro. Dr. Berman is a diplomate of the American Board of Psychiatry and Neurology (ABPN) in Adult and Addiction Psychiatry as well as Psychosomatic Medicine. He has been certified by the American Society of Addiction Medicine since 1988 and is Board Certified in Addiction Medicine (ABAM). Dr. Berman’s area of special interest in research and teaching is Pain Management and Co-occurring Opioid Dependence. He is also a strong advocate for Medication Assisted Treatment (MAT) for the chronic persistent mentally ill. Dr. Berman participated in NIDA’s clinical trials of Buprenorphine/Naloxone for treatment of heroin addiction in 2001. Since then he has developed innovative treatment programs for individuals with Co-occurring disorders as well as Substance Use Disorders. Dr. Berman served as Chief of Psychiatry at Fort Leavenworth, KS including the Department of Defense’s US Disciplinary Barracks located at Fort Leavenworth. He recently retired from the US Army Reserve after 22 years of service which included service in Operations Desert Storm and Iraqi Freedom. He is currently the Psychiatric Consultant to the Department of Immigration Health (DIHS), a division of Homeland security. Prior to coming to New Jersey, he served as Medical Director of Gieisinger Health Care’s Marworth chemical dependency center and consultant to pain management centers in New Jersey and Pennsylvania for issues of addiction, pain and co-occurring mood disorders. He has taken an active role in the medical treatment of HIV patients in all of these clinical settings.

William D Stanley, born and raised in Baltimore, MD, attended UMDNJ-Robert Wood Johnson Medical school. Later, he did his internship and residency at Albert Einstein Med Center in Philadelphia. Initially, he practiced primary care for many years but due to the influence of many people—in particular, Dr. Lou Baxter—his eyes gravitated to the world of substance abuse. Dr. Stanley became certified by the American Board of Addiction Medicine in 2000. He initially focused on outpatient treatment of opioid dependence with Suboxone and, more recently, Vivitrol. He was invited to join the family of Summit Behavioral Health in 2013 part-time and started full-time as the medical director of their detox in December 2014.

Gershon has been managing substance use disorder treatment programs for over 25 years. He has deep experience in integrating treatment of co-occurring disorders, trauma, gender-specific issues and anger management into drug and alcohol treatment. Gershon has provided clinical leadership in residential, outpatient and prevention programs. He directed a residential mother/child program for 7 years as well as an IOP for substance use disorders in an outpatient psychiatric setting for 7 years. Gershon’s philosophy of treatment is a person-centered collaboration between client and program, a therapeutic alliance that promotes personal responsibility in the client and emotional support by the program. Clients are viewed as individuals with their own strengths who may need to negotiate developmental challenges or social skill deficits in order to meet their own goals for a satisfying life. Gershon believes in being personally available to patients and their approved collaterals.